"Placebo Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
| Descriptor ID |
D015990
|
| MeSH Number(s) |
N05.715.350.350.625 N06.850.490.734.875
|
| Concept/Terms |
Placebo Effect- Placebo Effect
- Effect, Placebo
- Effects, Placebo
- Placebo Effects
|
Below are MeSH descriptors whose meaning is more general than "Placebo Effect".
Below are MeSH descriptors whose meaning is more specific than "Placebo Effect".
This graph shows the total number of publications written about "Placebo Effect" by people in this website by year, and whether "Placebo Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 3 | 2 | 5 |
| 2012 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Placebo Effect" by people in Profiles.
-
Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication. Appl Psychol Health Well Being. 2024 Nov; 16(4):2026-2047.
-
Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial. Pain. 2022 05 01; 163(5):910-922.
-
Diverse predictors of treatment response to active medication and placebo in gambling disorder. J Psychiatr Res. 2021 12; 144:96-101.
-
The placebo effect: To explore or to exploit? Cognition. 2021 09; 214:104753.
-
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019 08; 5(8):eaaw7756.
-
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups. Circulation. 2019 08 27; 140(9):739-750.
-
Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLoS One. 2018; 13(4):e0193544.
-
Placebo response in trichotillomania. Int Clin Psychopharmacol. 2017 11; 32(6):350-355.
-
The placebo effect and its clinical associations in gambling disorder. Ann Clin Psychiatry. 2017 Aug; 29(3):167-172.
-
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Circulation. 2016 Dec 13; 134(24):1931-1943.